This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Julia Glunz: Innovator in Antibody Research
Introduction
Julia Glunz is a notable inventor recognized for her contributions to the field of antibody research. She is currently associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. With a focus on innovative solutions, Julia has made significant strides in her area of expertise.
Latest Patents
Julia holds a patent titled "ANTI-A2AP ANTIBODIES AND USES THEREOF." This patent represents her commitment to advancing medical science and improving therapeutic options. She has a total of 1 patent to her name, showcasing her innovative capabilities.
Career Highlights
Throughout her career, Julia has demonstrated a strong dedication to research and development. Her work at Bayer Aktiengesellschaft has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to science.
Collaborations
One of her notable collaborators is Melanie Fischer, who works alongside Julia in their research endeavors. Together, they strive to push the boundaries of what is possible in antibody development.
Conclusion
Julia Glunz is a pioneering inventor whose work in antibody research is making a significant impact in the medical field. Her dedication to innovation and collaboration continues to drive advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile